Squamous cell carcinoma of the oral cavity+4
RecruitingStudy on the Safety and Effectiveness of Afatinib for Fanconi Anemia Patients with Advanced Squamous Cell Carcinoma in the Oral Cavity, Oropharynx, Hypopharynx, or Larynx
Study on the Safety and Effectiveness of Afatinib for Fanconi Anemia Patients with Advanced Squamous Cell Carcinoma in the Oral Cavity, Oropharynx, Hypopharynx, or Larynx
- Disease:Squamous cell carcinoma of the oral cavityOropharyngeal squamous cell carcinoma+3
- Substances:Afatinib
Germany- Participants:18–64 years · 65+ years
- Substances:Afatinib





